Item 2.01. Completion of Acquisition of Disposition of Assets.

The disclosure set forth in the "Introductory Note" above is incorporated into this Item 2.01 by reference. The material provisions of the Merger Agreement are described in the Final Proxy Statement/Prospectus in the section titled "The Merger Agreement", which description is incorporated herein by reference.

As previously reported in the Current Report on Form 8-K filed with the SEC on August 16, 2021, CF III held a special meeting of its stockholders on August 12, 2021 (the "Special Meeting"). At the Special Meeting, the CF III stockholders considered and adopted, among other matters, the Merger Agreement. Prior to the Special Meeting, the holders of 19,355,365 shares of CF III's common stock sold in its initial public offering ("Public Shares") exercised their right to redeem those shares for cash at a price of $10.10 per share, for an aggregate of approximately $195.5 million. The per share redemption price of $10.10 for holders of Public Shares electing redemption was paid out of CF III's trust account, which after taking into account the redemptions, had a balance immediately prior to the Closing of approximately $36.8 million.





                                       2

--------------------------------------------------------------------------------

On the Closing Date, the following transactions (collectively, the "Transactions") were completed:





           •     Merger Sub merged with and into AEye Technologies, with AEye
                 Technologies surviving as a wholly-owned subsidiary of the
                 Company;




           •     each share of common stock of Merger Sub issued and outstanding
                 immediately prior to the Effective Time was automatically
                 converted into an equal number of shares of common stock of
                 validly issued, fully paid and nonassessable shares of common
                 stock of AEye Technologies, which shares shall constitute the only
                 outstanding shares of capital stock of AEye Technologies to be
                 held by the Company;




           •     all issued and outstanding shares of AEye Technologies' capital
                 stock (other than shares held by the Company, Sponsor or held in
                 treasury) converted into an aggregate of 122,509,667 shares of
                 Common Stock.




           •     all shares of AEye Technologies' capital stock held in treasury
                 were canceled without any conversion thereof;




           •     all of the outstanding options of AEye Technologies to acquire
                 AEye Technologies' common stock were assumed by the Company and
                 converted into options to acquire an aggregate of 29,415,292
                 shares of Common Stock;




           •     all of the outstanding restricted stock units ("RSUs") of AEye
                 Technologies to acquire AEye Technologies' common stock were
                 assumed by the Company and converted into RSUs to acquire an
                 aggregate of 1,724,283 shares of Common Stock;




           •     all of the 5,750,000 outstanding shares of CF III's Class B common
. . .

Item 3.02. Unregistered Sales of Equity Securities

PIPE Subscription Agreement

Contemporaneously with the execution of the Merger Agreement, CF III entered into separate PIPE Subscription Agreements in a private placement with a number of PIPE investors, pursuant to which the PIPE Investors agreed to purchase, and CF III agreed to sell to the PIPE Investors, an aggregate of 22,000,000 shares of Common Stock, for a purchase price of $10.00 per share and an aggregate purchase price of $220 million. CF III also entered into a PIPE Subscription Agreement for 500,000 shares of Common Stock, for a purchase price of $10.00 per share and an aggregate purchase price of $5 million with an investor who defaulted on the Closing Date under the PIPE Subscription Agreement. The Company plans to aggressively pursue its available remedies with respect to such investor.





                                       27

--------------------------------------------------------------------------------

In accordance with the terms of the PIPE Subscription Agreements, on August 16, 2021 the Company issued 22,000,000 unregistered securities to the PIPE Investors. The shares of Common Stock issued pursuant to the Subscription Agreements were not registered under the Securities Act of 1933 (the "Securities Act") and were issued in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.

This summary is qualified in its entirety by reference to the PIPE Subscription Agreements, the form of which is included as Exhibit 10.1 to this Current Report and is incorporated herein by reference.

Item 3.03. Material Modification to Rights of Security Holders

Second Amended and Restated Certificate of Incorporation

Immediately prior to the Closing of the Business Combination, CF III's amended and restated certificate of incorporation, dated November 12, 2020 (the "Charter"), was further amended and restated to:





  (a) change the post-combination company's name to AEye, Inc.;




    (b)  change the nature of the business or purpose of the post-combination
         company to "any lawful act or activity for which corporations may be
         organized under the DGCL;




    (c)  eliminate the Class B common stock (after giving effect to the conversion
         of each outstanding share of Class B common stock immediately prior to
         the Closing of the Business Combination into one share of Common Stock)




    (d)  increase the term for directors from two (2) years to three (3) years and
         add a third class of directors.




    (e)  amend certain terms in Article XI (Corporate Opportunities) with respect
         to certain non-employee directors of the post-combination company
         pursuing outside business activities and corporate opportunities; and




    (f)  delete other provisions applicable only to blank check companies, and
         make conforming changes to reflect such deletions.

As previously reported in the Current Report on Form 8-K filed with the SEC on August 16, 2021, the CF III stockholders approved this second amendment and restatement of the Charter at the Special Meeting. This summary is qualified in its entirety by reference to the text of the second amended and restated certificate of incorporation, which is included as Exhibit 3.1 hereto and incorporated herein by reference.

Amended and Restated Bylaws

Upon the Closing of the Business Combination, CF III's bylaws were amended and restated to be consistent with Company's amended and restated certificate of incorporation and to make certain other changes that the Board deemed appropriate for a public operating company. The amended and restated bylaws are filed as Exhibit 3.2 hereto and incorporated herein by reference.





                                       28

--------------------------------------------------------------------------------

Item 5.01. Changes in Control of Registrant.

Reference is made to the disclosure in the Final Proxy Statement/Prospectus in the section titled "The Business Combination Proposal," which is incorporated herein by reference. Further reference is made to the information set forth above under "Introductory Note" and contained in Item 2.01 "Completion of Acquisition or Disposition of Assets" to this Report, which is incorporated herein by reference.

Immediately after giving effect to the Business Combination, there were approximately 154,404,302 million shares of Common Stock outstanding. As of such time, the Company's officers and directors and their affiliated entities held approximately 15.2% of the Company's outstanding shares of Common Stock.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.


Appointment of Directors and Officers

The following persons are serving as executive officers and directors of the Company upon the Closing, with Blair LaCorte, Luis Dussan, Robert Brown, Thomas R. Tewell and Andrew S. Hughes having been named as executive officers effective upon the Closing on August 16, 2021, and each of the directors having been elected by the CF III stockholders to the Board also upon the Closing on August 16, 2021. For biographical and current





                                       29

--------------------------------------------------------------------------------

compensatory information concerning the executive officers and directors, see the disclosure in the Final Proxy Statement/Prospectus in the sections titled "Management of the Combined Entity Following the Business Combination" which is incorporated herein by reference.





Name                  Age                               Position
Blair LaCorte         58     Chief Executive Officer and Director
Luis Dussan           46     Chief Technology Officer, Chief Product Strategist and Director
Robert Brown          56     Treasurer, Chief Financial Officer and Chief Accounting Officer
Thomas R. Tewell      54     Chief Operating Officer
Andrew S. Hughes      55     Secretary and General Counsel
Wen Hsieh             48     Director
Prof. Dr. Bernd
Gottschalk            77     Director
Dr. Karl-Thomas
Neumann               60     Director
Timothy J. Dunn       63     Director
Carol DiBattiste      69     Director

Effective upon the Closing on August 16, 2021, Howard W. Lutnick, Anshu Jain and Jane Novak resigned as executive officers of CF III and Howard W. Lutnick, Anshu Jain, Robert G. Sharp and Robert J. Hochberg resigned as directors of CF III.

The Board is classified into three classes, each comprising as nearly as possible one-third of the directors to serve three-year terms. As Class I directors, each of Wen Hsieh and Timothy J. Dunn will serve until the Company's 2022 annual meeting; as Class II directors, each of Luis Dussan and Dr. Karl-Thomas Neumann will serve until the Company's 2023 annual meeting; and as Class III directors, each of Blair LaCorte, Prof. Dr. Bernd Gottschalk and Carol DiBattiste will serve until the Company's 2024 annual meeting, or in each case until their respective successors are duly elected and qualified, or until their earlier resignation, removal or death.

2021 Equity Incentive Plan

As previously reported in the Current Report on Form 8-K filed with the SEC on August 16, 2021, at the Special Meeting, the CF III stockholders considered and approved the CF Finance Acquisition Corp. III 2021 Equity Incentive Plan (the "Incentive Plan"), and reserved 21,541,913 shares of Common Stock for issuance thereunder. The Incentive Plan was previously approved, subject to stockholder approval, by the board of directors of CF III on February 17, 2021. The Incentive Plan became effective immediately upon the Closing of the Business Combination. The number of shares of Common Stock reserved for issuance under the Incentive Plan will automatically increase on January 1 of each year, beginning on January 1, 2022 and continuing through January 1, 2032, by 5% of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Board.

A more complete summary of the terms of the Incentive Plan is set forth in the Final Proxy Statement/Prospectus in the section titled "The Equity Incentive Plan Proposal". That summary and the foregoing description of the Incentive Plan are qualified in their entirety by reference to the text of the Incentive Plan, which is filed as Exhibit 10.3 hereto and incorporated herein by reference.





                                       30

--------------------------------------------------------------------------------

Indemnification Agreements for Company Directors and Officers

In connection with the Closing of the Business Combination, the Company entered . . .

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal


           Year


The information set forth in Item 3.03 to this Current Report on Form 8-K is incorporated by reference into this Item 5.03.

Item 5.06. Change in Shell Company Status.

As a result of the Business Combination, the Company ceased being a shell company (as defined in Rule 21b-2 of the Exchange Act) as of the Closing Date. Reference is made to the disclosure in the Final Proxy Statement/Prospectus in the section titled "The Business Combination Proposal," which is incorporated herein by reference. Further reference is made to the information contained in Item 2.01 to this Current Report on Form 8-K.

Item 8.01. Other Events

As a result of the Business Combination and by operation of Rule 12g-3(a) promulgated under the Exchange Act, AEye Inc. is a successor issuer to CF Finance Acquisition Corp. III. AEye Inc. hereby reports this succession in accordance with Rule 12g-3(f) under the Exchange Act.

Item 9.01. Financial Statement and Exhibits.

(a)-(b) Financial Statements.

The audited balance sheet of CF III., as of December 31, 2020 and 2019, and the related statements of operations, stockholders' equity, and cash flows for the year ended December 31, 2020 and 2019, and the related notes thereto and report of independent registered public accounting firm, included in the Final Proxy Statement/Prospectus in the section titled "Index to Financial Statements- Audited Financial Statements of CF Finance Acquisition Corp. III" are incorporated herein by reference.

The audited consolidated balance sheets of AEye Technologies as of December 31, 2020 and 2019, the related consolidated statements of operations, other comprehensive income loss, shareholders' equity, and cash flows for each of the years in the two-year period ended December 31, 2020, and the related notes thereto and report of independent registered public accounting firm, included in the Final Proxy Statement/Prospectus in the section titled "Index to Financial Statements- Audited Financial Statements of AEye, Inc." are incorporated herein by reference.

The unaudited pro forma combined financial information of the Company for the year ended December 31, 2020 and for the six months ended June 30, 2021 is set forth in Exhibit 99.1 hereto and is incorporated herein by reference.

The unaudited financial statements of AEye Technologies, Inc. as of June 30, 2021 and for the six months ended June 30, 2021 are filed with this Current Report on Form 8-K as Exhibit 99.2 and incorporated herein by reference.





                                       31

--------------------------------------------------------------------------------


(d) Exhibits.



Exhibit
Number       Description

2.1*           Merger Agreement, dated as of February 17, 2021, by and among the
             Company, Merger Sub and AEye Technologies (included as Annex A-1 to
             the Final Proxy Statement/Prospectus filed under Rule 424(b)(3) (File
             No. 333-256058) on July 21, 2021)

2.2*           Amendment to the Merger Agreement, dated as of April 30, 2021, by
             and among the Company, Merger Sub and AEye Technologies (included as
             Annex A-2 to the Final Proxy Statement/Prospectus filed under Rule
             424(b)(3) (File No. 333-256058) on July 21, 2021)

3.1            Second Amended and Restated Certificate of Incorporation of AEye,
             Inc.

3.2            Amended and Restated Bylaws of AEye, Inc.

10.1*          Form of PIPE Subscription Agreement (incorporated by reference to
             Exhibit 10.1 filed on the Registrant's Current Report on Form 8-K
             (File No. 001-39699), filed on February 17, 2021)

10.2           Form of Indemnification Agreement

10.3*          2021 Equity Incentive Plan (included as Annex A-1 to the Final Proxy
             Statement/Prospectus filed under Rule 424(b)(3) (File No. 333-256058)
             on July 21, 2021)

99.1           Unaudited Pro Forma Condensed Combined Financial Information of the
             Company as of December 31, 2020 and for the Six Months ended June 30,
             2021

99.2           Unaudited Consolidated Financial Statements of AEye, Inc. for the
             Six Months ended June 30, 2021

104          Cover Page Interactive Data File




* Filed previously




                                       32

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses